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1. Introduction 
The sequence of the activation peptide liberated 
during the conversion of trypsinogen into active 
trypsin has been determined in several mammalian 
species [l-l 2] .and in two fishes, the dogfish and 
the lungfish [ 13- 151. It is an N-terminal peptide 
whose general structure is X-Asp-Asp-Asp-Asp-Lys 
in all cases except the lungfish whose sequence is 
Phe-Pro-Ile-Glu-Glu-Asp-Lys. The length of the 
peptide varies from 6 to 8 amino acid residues 
according to the species. 
The determination of the different sequences has 
permitted to establish phylogenetic relationship 
between species on purely biochemical date. Moreover, 
the physiological importance of this peptide has been 
demonstrated by Abita et al. [ 161 who observed on 
inhibitory effect on gastric secretion. These observa- 
tions underline the interest of the characterization of 
the activation peptides of human trypsinogens. 
In this work, we report the isolation and sequence 
of the activation peptide of human trypsinogen 2, the 
most anionic trypsinogen isolated from human 
pancreatic juice [ 171. 
2. Materials and methods 
2.1. Materials 
Human trypsinogen 2 was isolated from pancreatic 
juice according to the method described previously [ 181. 
*Present address: Brookhaven National Laboratory, Biology 
Department. Upton - New York 11973 - 
Trypsin inhibitor-Sepharose was prepared by activat. 
ing Sepharose 4B with cyanogen bromide and couplgg 
activated Sepharose with kallikreintrypsin-inhibitor 
(Bayer AG) according to the procedure of Cuatrecasas 
et al. [19]. 
2.2. Activation of trypsinogen 
12 mg of trypsinogen were dissolved in 4 ml of 
activation buffer (5 mM Tris-HCl buffer containing 
20 mM CaClz and 40 mM NaCl) at 0°C. When the pH 
was adjusted at 7.8 generally trypsinogen activated 
spontaneously. When the activation was too slow, 
120 1.18 of pure porcine enterokinase (a gift of 
Dr S. Maroux) were added to the activation mixture. 
After 2 h, the activity reached a maximal constant 
value and the activation was stopped by inhibition 
of trypsin with kallikrein trypsin inhibitor coupled 
to Sepharose. 
2.3. Isolation of the activation peptide 
The activation mixture was submitted to an affinity 
chromatography on a column of trypsin inhibitor- 
Sepharose (0.9 X 10 cm) equilibrated at pH 7.8 with 
the activation buffer containing 0.2 M NaCl. The 
peptides eluted with the breakthrough peak were 
lyophilised and filtered through a column of Sephadex 
G-25 (fine) (0.9 X 200 cm) equilibrated with 10% 
acetic acid. The activation peptide was finally 
purified by high voltage electrophoresis at pH 5.3 
on Whatman 3 MM at 3000 V for 35 min. The 
peptide was eluted from paper by the mixture 
pyridine-water (l/l by vol.) and analyzed. 
2.4. Peptide analysis 
Peptides were detected by reaction of aliquots 
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Table 1 A 570nm 
Analysis of the activation peptide of hyman trypsinogen 2. 
The underlined numbers show the residues released by one 
cycle of subtractive Edman degradation 
LYS ASP Pro Ala Phe 
Amino acid 
composition 
1.04 4.02 1.12 0.78 0.86 
Edman degra- 
dation 
- step 1 0.71 4.10 1.28 024 _L 0.90 
- step 2 0.58 4.00 0.55 0.28 0.84 - 
of column effluents with ninhydrin following alkaline 
hydrolysis. Absorbance was read at 570 nm. Amino 
acid compositions of peptides were determined using 
a Jeol Analyzer 5 AH, after 18 h hydrolysis at 110°C 
with 6 N HCl in evacuated sealed tubes. 
N-terminal residues of peptides were identified by 
dansylation according to Hartley [20] or by Edman 
degradation using a subtractive procedure [21]. 
3. Results and discussion 
Filtration of peptides on Sephadex G-25 is repre- 
sented in fig.1. Fractions corresponding to the major 
bk A 
Fig.1. Gel filtration on Sephadex C-25 of peptides liberated 
by activation of trypsinogen 2. The column (0.9 X 200 cm) 
was equilibrated with 10% acetic acid. The effluent was 
collected in 2.2 ml fraction. Peptides were located by 
ninhydrin analysis after alkaline hydrolysis. 
peak of absorption at 570 nm (pool A) were pooled, 
concentrated and submitted to paper electrophoresis. 
The peptide map is reproduced in fig.2. After analysis 
of the different spots, the activation peptide (hatched 
spot) was found in the anodic part as expected, due 
to the presence of several aspartic acid residues. Table 
1 gives the amino acid composition and two steps of 
Edman degradation of this peptide. The N-terminal 
Table 2 
Sequences of activation peptides of trypsinogens of different species 
Dogfnh 
Lungtish 
Horse 
Elephant seal 
Lesser rorqual 
Dromedary 
Red deer 
Roe deer 
Sheep 
Bovine 
{ 
cationic trypsinogen 
anionic trypsinogen 
Porcine ( 
cationic trypsinogen 
anionic trypsinogen 
Ala -Pro -Asp-Asp-Asp-Asp-Lys 
Phe-Pro-Be -Glu-Glu-Asp-Lys 
Ser -Ser -Thr-Asp-Asp-Asp-Asp-Lys 
Phe-Pro -Th-Asp-Asp-Asp-Asp-Lys 
Phe-Pro-Be -Asp-Asp-Asp-Asp-Lys 
W-Pro-Be -Asp-Asp-Asp-Asp-Lys 
Phe-Pro -Val -Asp-Asp-Asp-Asp-Lys 
Val-Asp-Asp-Asp-Asp-Lys 
Phe-Pro-Val-Asp-Asp-Asp-Asp-Lys 
V;d-Asp-Asp-Asp-Asp-Lys 
Phe-Pro-VaI-Asp-Asp-Asp-Asp-Lys 
Val-Asp-Asp-Asp-Asp-Lys 
Phe-Pro-Val-Asp-Asp-Asp-Asp-Lys 
Val-Asp-Asp-Asp-Asp-Lys 
Val-Asp-Asp-Asp-Asp-Lys 
Phe-Pro-Ser -Asp-Asp-Asp-Asp-Lys 
Ser -Asp-Asp-Asp-Asp-Lys 
Phe-Pro -Tbr-Asp-Asp-Asp-Asp-Lys 
Phe-Pro-Thr-Asp-Asp-Asp-Asp-Lys 
Bradshaw et al. [ 131 
Hermodson et al. [ 141 
Harris and Hofmann [ 81 
Bricteux et al. [ 10) 
Bricteux et al. [ 111 
Bricteux et al. [ 91 
Bricteux et al. [ 7 ] 
Bricteux [ 61 
Bricteux et al. [4] 
Bricteux et al. [ 5 J 
Davie and Neurath [l] 
Louvard and Puigserver [121 
Charles et al. [ 21 
Louvard and Puigserver [121 
151 
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9 
val-ASp4-LyS 
48 
Neutral AA 
3 
Fig.2. Reproduction of the high-voltage paper electrophoresis 
of pool A eluted from Sephadcx G-25. On the left, a mixture 
of standard amino acids containing the activation peptide of 
bovine trypsinogen, Val-(Asp),-Lys, is given as reference. 
residue of alanine was characterized by Edman degrada- 
tion and by dansylation. These results lead to the 
conclusion that the activation peptide of human 
trypsinogen 2 is an octapeptide with the sequence: 
Ala-Pro-Phe-Asp-Asp-Asp-Asp-Lys 
Like all mammalian trypsinogens except the bovine 
cationic one (table 2) the activation peptide of human 
trypsinogen 2 is an octapeptide containing the con? 
stant sequence Asp-Asp-Asp-Asp-Lys. It is 
interesting to note the persistance of proline in posi- 
tion 2 as in each mammalian octapeptide except for 
that of the horse. The occurrence of phenylalanine in 
position 3 of the peptide from human trypsinogen 2 
makes it unlike any of the previously described 
octapeptides where phenylalanine, if present, 
occupies position 1. This replacement and the 
substitution of the N-terminal residue of phenylalanine 
by a residue of alanine which requires two base 
152 
mutations raises the question of the hypothetical 
ancestral sequence of the activation peptides. The 
sequence of the activation peptide of human trypsi- 
nogen 2 would favor the ancestral sequence Ala-Pro- 
Ile-(Asp)4-Lys one of the two ancestral sequences 
proposed by Reeck and Neurath [ 151. 
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